Skip to content
Screener

eXoZymes, Inc. EXOZ Q1 2026 earnings

Reported May 14, 2026 · Before market open

EPS-$0.28

Next report

Date not yet announced

Financials

Q1 2026

Income statement

See full
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$63.09M—
Enterprise value$62.85M—

Returns & leverage

See full
Return on equity-185.8%—
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

FAQ

When did eXoZymes, Inc. report Q1 2026 earnings?
eXoZymes, Inc. (EXOZ) reported Q1 2026 earnings on May 14, 2026 before market open.
What were eXoZymes, Inc.'s Q1 2026 revenue and EPS?
eXoZymes, Inc. reported eps of $-0.28 for Q1 2026.
How did eXoZymes, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 27.3% from $-0.22.
Where can I find eXoZymes, Inc.'s Q1 2026 SEC filings?
You can read the 10-Q periodic report (0001493152-26-023035) directly on SEC EDGAR. The filing index links above go to sec.gov.